Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 863 | 916 | 933 | 946 | 336 |
| Marketable Securities | N/A | N/A | N/A | N/A | 1,238 |
| TOTAL | $919 | $956 | $987 | $1,101 | $1,766 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 61 | 67 | 149 | 81 | 86 |
| TOTAL | $61 | $67 | $149 | $81 | $86 |
| Total Assets | $980 | $1,023 | $1,136 | $1,182 | $1,852 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 70 | 77 | 60 | 58 | 607 |
| TOTAL | $70 | $77 | $134 | $132 | $681 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $70 | $77 | $134 | $132 | $681 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29 | 29 | 29 | 29 | 34 |
| Retained earnings | -3,323 | -3,287 | -3,231 | -3,183 | -3,130 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | -108 |
| TOTAL | $910 | $946 | $1,002 | $1,050 | $1,172 |
| Total Liabilities And Equity | $980 | $1,023 | $1,136 | $1,182 | $1,852 |